ArticleJournal of global health2026
Association of sleep and glycaemic status with all-cause mortality: a prospective cohort study.
Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Suboptimal sleep and diabetes are major contributors to mortality. However, whether sleep patterns differentially affect mortality across glycaemic statuses remains unclear. This study examined associations of sleep patterns (sleep duration and sleep disorders) with all-cause mortality among individuals with normoglycaemia, prediabetes, and diabetes. Methods: Data were obtained from the Taiwan MJ cohort, including 534 238 participants enrolled between 1996 and 2022. Sleep duration ('less than 6 hours', '6-8 hours', 'more than 8 hours') and sleep disorders (yes/no) were assessed via standardised questionnaires. Glycaemic status was classified as normoglycaemia, prediabetes, or diabetes. Mortality data were obtained from the Taiwan Death Registry. Cox proportional hazards regression models were employed to evaluate the association between sleep patterns and the risk of all-cause mortality. Results: The study included 363 863 participants with normoglycaemia, 144 602 with prediabetes, and 25 773 with diabetes. Over a median follow-up period of 19 years, 52 208 deaths were recorded. Compared with those who slept 6-8 hours, normoglycaemia individuals who slept less than 6 hours had a higher risk of all-cause mortality (hazard ratio (HR) = 1.05; 95% confidence interval (CI) = 1.02-1.08) and those who slept more than eight hours had a higher risk of all-cause mortality across all glycaemic groups: normoglycaemia (HR = 1.19; 95% CI = 1.15-1.24), prediabetes (HR = 1.24; 95% CI = 1.19-1.30), and diabetes (HR = 1.29; 95% CI = 1.22-1.36). Sleep disorders were also associated with increased mortality among individuals with prediabetes (HR = 1.04; 95% CI = 1.01-1.07) and diabetes (HR = 1.07; 95% CI = 1.02-1.11). Conclusions: Long sleep durations and sleep disorders were associated with increased mortality, especially among individuals with impaired glucose regulation while short sleep duration was discovered to associate with increased risk of mortality in people with normoglycaemia. These findings highlight the potential role of sleep assessment in risk stratification, although the observational nature of the study limits causal inference.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.